|
|
|
Company
Name |
Short
Summary |
| Acadia
Pharmaceuticals |
Acadia
Pharmaceuticals is an integrated drug discovery
company focused on the identification of novel
lead compounds for the treatment of Central Nervous
Systems disorders. |
| Accelovance |
Accelovance is focused on providing full-Service CRO services, clinical sites, and patient recruitment for biotechnology, pharmaceutical, and medical device companies. |
| Accumetrics |
Accumetrics
is a biotech company focused on the design, development,
manufacturing, and marketing of innovative point-of-care
cardiovascular diagnostic products. |
| ACON Laboratories |
ACON Laboratories is focused on the development and commercialization of rapid diagnostic tests. |
| ADVENTRX Pharmaceuticals |
ADVENTRX Pharmaceuticals is a biopharmaceutical company focused on proprietary product candidates primarily for the treatment of cancer. |
| Agilent Technologies |
Agilent
Technologies is a global, diversified technology
company focusing on high-growth markets in the communications,
electronics, life sciences and healthcare industries |
| Alere |
Alere is focused on combining diagnostics with health management services to help determine the best course of treatment. |
| Allermed Laboratories |
Allermed Laboratories is a supplier of allergenic extracts for the diagnosis and treatment of allergic disorders. |
| Alliance
Pharmaceutical |
Alliance's
products are intended primarily for use during
acute care, critical situations including surgical,
cardiology, and respiratory indications. |
| Allylix |
Allylix has developed proprietary technology that allows it to produce terpenes at low cost. |
| Althea Technologies |
Althea Technologies is a fully-integrated contract development and manufacturing organization. |
| Ambit Biosciences |
Ambit Biosciences is focused on the discovery and development of small-molecule kinase inhibitors for the treatment of cancer. |
| Amira Pharmaceuticals |
Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory disease. |
| Amylin
Pharmaceuticals |
Amylin
Pharmaceuticals, Inc. is a development pharmaceutical
company focused on metabolic disorders with a
concentration in diabetes. |
| Anadys Pharmaceuticals |
Anadys Pharmaceuticals is a biopharmaceutical company dedicated to improving patient care by developing novel medicines for the treatment of hepatitis C. |
| AnaptysBio |
AnaptysBio, Inc is a therapeutic antibody company focused on the use of somatic hypermutation (SHM) for antibody discovery and optimization. |
| Apricus Biosciences |
Apricus Biosciences is focused on the development and commercialization of drugs across numerous therapeutic classes. |
| Aptiv Solutions |
Aptiv Solutions is focused on providing drug and medical device development services. |
| AquaBounty Technologies |
AquaBounty Technologies is focused on the application of biotechnology to improving productivity in commercial aquaculture. |
| Ardea Biosciences |
Ardea Biosciences is focused on the research and development of small-molecule therapeutics with an initial focus on gout, cancer, and HIV. |
| Arena
Pharmaceuticals |
Arean
Pharmaceuticals is involved in developing a broad
pipeline of compounds that act on G protein-coupled
receptors, or GPCRs. |
| AVIVA Biosciences |
AVIVA Biosciences is focused on the research, development, and commercialization of cell-based assays. |
| Becton Dickinson |
Becton Dickinson
manufactures and sells medical supplies and devices
and diagnostic systems for use by healthcare professionals,
research institutions, industry and the general public. |
| BioAtla |
BioAtla is a biological service company specializing in next generation protein and antibody engineering and evolution services. |
| Biocept |
Biocept is focused on using cell separation technology to develop diagnostic assays for personalized medicine in early detection, diagnosis and monitoring of cancer. |
| BioMedica |
BioMedica is focused on the development of novel gene-based therapeutics for the treatment of cancer, neurodegenerative diseases and other disorders. |
| Biogen Idec |
Biogen Idec is focused on research, development, and commercialization of products in neurology, oncology and immunology. |
| Biosite
Diagnostics |
Biosite
Diagnostics develops, manufactures and markets
rapid, accurate and cost-effective diagnostic
products that improve the quality of patient care
and simplify the practice of laboratory medicine. |
| BioSurplus |
BioSurplus is focused on providing equipment management solutions and pre-owned scientific instruments to the life sciences industry. |
| BrainCells |
BrainCells is focused on the development and application of a proprietary neurogenic platform technology includes state-of-the-art human neural stem cell based and animal-based assays. |
| Cadence Pharmaceuticals |
Cadence Pharmaceuticals focused on in-licensing, developing and commercializing proprietary product candidates principally perscribed and used in the hospital setting. |
| Calmune |
Calmune Corporation is focused on development of antibody therapeutics. |
| Carolus Therapeutics |
Carolus Therapeutics is focused on the development drugs to treat disorders triggered by acute and chronic inflammation. |
| Cato
Research |
Cato Research is a global is
a full-service contract research and development
organization (CRO). |
| Celgene
|
Celgene
is a pharmaceutical company with a major focus
on the discovery, development and commercialization
of small molecules for cancer and immunological
diseases. |
| Ceregene |
Ceregene is focused on the treatment of major neurodegenerative diseases by unique delivery of nervous system growth factors. |
| Charles
River Laboratories |
Charles River Laboratories is a global provider of solutions that advance the drug discovery and development process. Charles River Laboratories is the
largest laboratory animal production company in
the world, and also offers a number of preclinical and clinical support capabilities. |
| ChemDiv |
ChemDiv is a contract discovery and development organization. ChemDiv is a provider of integrated discovery and development solutions focused on a chemistry platform. |
| Clinimetrics |
Clinimetrics
Research Associates, Inc. is an international,
full service contract research organization (CRO)
founded in 1988 to provide clinical research support
to the pharmaceutical, biotechnology and medical
device industries. |
| Conatus Pharmaceuticals |
Conatus Pharmaceuticals is focused on the development of drugs to treat liver disease |
| Cypress
Bioscience |
Cypress
Bioscience, Inc. develops, manufactures and markets
medical devices and therapeutics for the treatment
of certain types of immune disorders. |
| Cytori Therapeutics |
Cytori Therapeutics is focused on the development and commercialization of the Celution® System, which isolates stem and regenerative cells from adipose tissue. |
| eBioscience |
eBioscience is focused on the research, development, and commercialization of antibodies, ELISAs and proteins for life science research and diagnostic applications. |
| EMD Chemicals |
EMD Chemicals is focused on providing industrial and laboratory chemicals for the pharmaceutical and biotechnology industry. |
| Exelixis |
Exelixis
is a rapidly growing, well-funded, privately held
biopharmaceutical company whose mission is to
identify novel therapeutic targets for drug discovery
by elucidating the biochemical pathways involved
in human diseases. |
| Fate Therapeutics |
Fate Therapeutics is focused on the research and development of therapeutics derived from stem cell biology. |
| Gen-Probe |
Gen-Probe
is the recognized world leader in the development,
manufacture and commercialization of diagnostic
products based on its patented genetic probe technology. |
| Genomatica |
Genomatica is focused on the development and application of it's Integrated Bioprocess Engineering Platform. This platform is an integrated suite of computational and experimental technologies used to design, create, and optimize novel high-performance microorganisms for chemical production. |
| Genzyme |
Genzyme
is a highly diversified family of companies committed
to redefining patient care worldwide through the
introduction of innovative products and services
for major unmet medical needs. |
| Halozyme Therapeutics |
Halozyme Therapeutics is a focused on products targeting the extracellular matrix for endocrinology, oncology, dermatology and drug delivery. |
| Harbor BioSciences |
Harbor BioSciences is focused on the research and develompent of novel adrenal steroid hormones and nutraceuticals. |
| Helicon Therapeutics |
Helicon Therapeutics is focused on the discovery, research, and development of therapeutics to treat disorders of cognition. |
| Histogen |
Histogen is focused on the research, development, and commerialization of products derived from the company's tissue-engineering platform. |
| Hospira |
Hospira is focused on commercialization of generic acute-care and oncology injectables and integrated infusion therapy and medication management solutions. Hospira also provides contract manufacturing services to pharmaceutical and biotechnology companies for injectable products. |
| HUYA Bioscience International |
HUYA Bioscience International is a is focused on global co-development of novel biopharmaceutical product opportunities originating in China. |
| IASO Pharma |
IASO Pharma is focused on the research and development of antimicrobials for the treatment of infectious diseases. |
| Ichor Medical Systems |
Ichor Medical Systems is focused on development of electroporation technology for the delivery of DNA drugs and vaccines. |
| Illumina |
Illumina is focused on the research, development, and manufacture of integrated systems for the analysis of genetic variation and biological function. |
| INC Research |
INC Research is a contract research organization (CRO) focused on managing clinical trials in cancer, infectious diseases, and central nervous system disorders. |
| InflammaGen Therapeutics |
InflammaGen Therapeutics is focused on the research and development of products for the diagnosis, treatment and prevention of multiple organ failure. |
| Inovio Biomedical Corporation |
Inovio Biomedical Corporation is focused on electroporation-based delivery of DNA vaccines. |
| iTherX |
iTherX is a focused on the discovery and development of treatments for Hepatitis C. |
| Ligand
Pharmaceuticals |
Ligand
Pharmaceuticals discovers, develops and markets
new drugs in the areas of cancer, skin diseases,
and men's and women's hormone related diseases,
as well as osteoporosis, metabolic disorders and
cardiovascular and inflammatory diseases. |
| Lpath |
Lpath is focused on the research and development of monoclonal antibodies that target bioactive lipids. |
| MabVax Therapeutics |
MabVax Therapeutics is focused on developing and commercializing vaccines and human antibodies for the treatment of cancer. |
| Marshall Edwards |
Marshall Edwards is focused on the research and develompent of small molecule therapeutics for treating patients with cancer. |
| MediciNova |
MediciNova is focused on the acquisition and development of small-molecule therapeutics for a treatment of a variety of diseases. MediciNova primarily acquires the rights to these products by in-licensing from mid-sized Japanese pharmaceutical companies. |
| MicroConstants |
MicroConstants is a GLP-compliant Contract Research Organization (CRO) providing bioanalytical, pharmacokinetics, drug metabolism, formulation analysis and immunoassay support services to pharmaceutical and biotech companies developing new chemical entities (NCEs). |
| Mixture
Sciences |
Mixture
Sciences, Inc., a privately-held biotechnology company,
specializes in biomedical research and drug discovery.
They use a combination of proprietary and in-licensed
technologies for the discovery of therapeutic and
diagnostic candidates for the treatment of HIV/AIDS,
cancer, diabetes, multiple sclerosis, and infectious
diseases, including Lyme Disease. Their technologies
have been validated and used by members of the academic
and corporate community over the past decade. |
| MultiGEN Diagnostics |
MultiGEN Diagnostics is is focused on the commercialization of DNA sequencing for routine clinical diagnosis in infectious disease. |
| Neurocrine
Biosciences |
Neurocrine
Biosciences is a leading neuroscience company
focused on the discovery and development of novel
therapeutics for neuropsychiatric, neuroinflammatory
and neurodegenerative diseases and disorders. |
| NuVasive |
NuVasive is focused on the development and commercialization of products for the surgical treatment of spine disorders. |
| Ocera Therapeutics |
Ocera Therapeutics is focused on the development of novel therapeutics in the areas of liver and gastrointestinal diseases. |
| OncoSec Medical |
OncoSec Medical is focused on the research and development of treatments for patients with advanced-stage skin cancer. |
| Optimer Pharmaceuticals |
Optimer Pharmaceuticals is focused on the research, development, and commercialization of anti-infectives. |
| Organovo |
Organovo is focused on the research and development of technology to provide three-dimensional tissue building capabilities for research and surgical applications. |
| Orphagen Pharmaceuticals |
Orphagen Pharmaceuticals is focused on the discovery, research and development of small molecule drugs which target orphan nuclear receptors for the treatment of patients with various diseases. |
| Pacira Pharmaceuticals |
Pacira Pharmaceuticals is focused on the research, development, and commercialization of products based on its proprietary DepoFoam® drug delivery technology with a focus in the post-surgical pain market. |
| PAREXEL International |
PAREXEL International is focuse on providing clinical development, regulatory affairs consulting, and commercialization services to biotechnology, pharmaceutical, and medical device companies. |
| Perceptive Informatics |
Perceptive Informatics is an eClinical solutions provider for the drug development process. |
| Pfenex |
Pfenex is focused on providing protein expression services for a broad range of applications including therapeutic proteins, vaccines, research reagents, and biosimilars. |
| PharmaNet Development Group |
PharmaNet Development Group is focused on providing drug development services to pharmaceutical, biotechnology, generic drug, and medical device companies. |
| Pharmatek Laboratories |
Pharmatek Laboratories is focused on providing pharmaceutical chemistry development and manufacturing services supporting pharmaceutical & biotechnology companies. |
| Polynoma |
Polynoma is focused on the development and commercialization of a therapeutic vaccine for the treatment of patients with melanoma. |
| PolyPeptide Laboratories |
PolyPeptide Laboratories is a contract manufacturing organization (CMO) focused on providing peptide synthesis services to biotechnology and pharmaceutical companies. |
| PPD |
PPD is focused on drug discovery, development and lifecycle management services to companies in the pharmaceutical, biotechnology, medical device industries. |
| PRA International |
PRA International is a Clinical Research Organization (CRO) focused on providing services for clinical development. |
| Prometheus
Laboratories |
Prometheus
Laboratories is involved in the disovery, development,
manufacture, and marketing of therapeutics and diagnostics
in the areas of gastrointestinal, autoimmune and
inflammatory diseases. |
| Promosome |
Promosome is focused on the development and commercialization of a technology which enhances protein synthesis for biotherapeutics. |
| Quidel |
Quidel is focused on the research, development, and commercialization of point-of-care, rapid diagnostic tests. |
| Quintiles |
Quintiles is a contract research organization focused on providing integrated bio and pharmaceutical services. Quintiles also offers commercial, consulting and capital services. |
| Receptos |
Receptos is focused on the research and development of candidates for the treatment of patients with autoimmune diseases using bioinformatics and structure driven drug discovery. |
| ResMed |
ResMed is focused on the development and commercialization of medical devices for the diagnosis, treatment, and management of sleep-disordered breathing. |
| RetroVirox |
RetroVirox is focused on the research and development of small molecule antivirals. |
| REVA Medical |
REVA Medical is focused on the development and commercialization of stent technologies. |
| Santarus |
Santarus
is involved in the acquisition, development, and
commercialization of drugs to treat gastrointestinal
diseases. |
| Senomyx |
Senomyx is focused on the discovery and development of flavor ingredients. |
| Sequel Pharmaceuticals |
Sequel Pharmaceuticals is focused development of cardiovascular drug candidates. |
| Sequenom |
Sequenom is focused on the development of discovery, clinical research, and molecular diagnostics asstas which precisely measures the amount of genetic target material and variations therein. |
| Sialix |
Sialix is focused on the research and development of immunotherapies against cancer using glycan structures present on the surface of tumor cells. |
| SRI |
SRI International is an independent, nonprofit research institute conducting client-sponsored research and development for government agencies, commercial businesses, foundations, and other organizations. SRI also brings its innovations to the marketplace by licensing its intellectual property and creating new ventures. |
| Strategic Enzyme Applications |
Strategic Enzyme Applications is focused on the application of biocatalysis for the design, development and implementation of process chemistries. |
| Synbiotics |
Synbiotics is focused on the development and commercialization of veterinary diagnostics and services. |
| Tioga Pharmaceuticals |
Tioga Pharmaceuticals is focused on the research, development, and commercialization of therapies for the treatment of patients with gastrointestinal diseases. |
| Tracon Pharmaceuticals |
Tracon Pharmaceuticals is focused on the development of antibody and small molecule therapies for people with cancer and related diseases. |
| Tragara Pharmaceuticals |
Tragara Pharmaceuticals is focused on the development of small molecule drugs for the treatment of various cancers. |
| Trius Therapeutics |
Trius Therapeutics is focused on the discovery, development and commercialization of antibiotics. |
| VentiRx Pharmaceuticals |
VentiRx Pharmaceuticals is focused on Toll-like receptor 8 (TLR8) therapeutics for the treatment of cancer, respiratory, and autoimmune diseases. |
| Verenium |
Verenium is focused on the research, development, and commercialization of enzymes for use in industrial processes. |
| Vertex
Pharmaceuticals |
The
Company has 12 drug candidates in development to
treat viral diseases, inflammation, cancer, autoimmune
diseases and neurological disorders. |
| Vical |
Vical
is involved in the discovery, research, and development
of products based on their DNA delivery technologies
(non-viral gene therapy) for the prevention and
treatment of serious or life-threatening diseases. |
| Volcano Corporation |
Volcano Corporation is focused on the development and commercialization of medical devices for the diagnosis and treatment of vascular and structural heart disease. |
| Zacharon Pharmaceuticals |
Zacharon Pharmaceuticals is focused on the development small molecule therapies target the biosynthesis of glycans. |
| Zogenix |
Zogenix is focused on the development and commercialization of products for the treatment of pain and central nervous system disorders. |
|
|
